Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors

Madson Q. Almeida, Kit Man Tsang, Chris Cheadle, Tonya Watkins, Jean-Charles B. Grivel, Maria Nesterova, Raphaela Goldbach-Mansky, Constantine A. Stratakis

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Patients with genetic defects of the cyclic (c) adenosine-monophosphate (AMP)-signaling pathway and those with neonatal-onset multisystem inflammatory disease (NOMID) develop tumor-like lesions of the long bones. The molecular basis of this similarity is unknown. NOMID is caused by inappropriate caspase-1 activity, which in turn activates the inflammasome. The present study demonstrates that NOMID bone lesions are derived from the same osteoblast progenitor cells that form fibroblastoid tumors in mice and humans with defects that lead to increased cAMP-dependent protein kinase A (PKA) signaling. NOMID tumor cells showed high PKA activity, and an increase in their cAMP signaling led to PKA-specific activation of caspase-1. Increased PKA led to inflammation-independent activation of caspase-1 via over-expression of the proto-oncogene (and early osteoblast factor) Ets-1. In NOMID tumor cells, as in cells with defective PKA regulation, increased prostaglandin E2 (PGE2) led to increased cAMP levels and activation of Wnt signaling, like in other states of inappropriate PKA activity. Caspase-1 and PGE2 inhibition led to a decrease in cell proliferation of both NOMID and cells with abnormal PKA. These data reveal a previously unsuspected link between abnormal cAMP signaling and defective regulation of the inflammasome and suggest that caspase-1 and PGE2 inhibition may be therapeutic targets in bone lesions associated with defects of these two pathways.

Original languageEnglish
Pages (from-to)165-175
Number of pages11
JournalHuman Molecular Genetics
Volume20
Issue number1
DOIs
Publication statusPublished - Jan 2011
Externally publishedYes

Fingerprint

Caspase 1
Cryopyrin-Associated Periodic Syndromes
Stromal Cells
Cyclic AMP-Dependent Protein Kinases
Osteoblasts
Cyclic AMP
Bone and Bones
Dinoprostone
Inflammasomes
Neoplasms
Proto-Oncogenes
Stem Cells
Cell Proliferation
Inflammation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions : A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. / Almeida, Madson Q.; Tsang, Kit Man; Cheadle, Chris; Watkins, Tonya; Grivel, Jean-Charles B.; Nesterova, Maria; Goldbach-Mansky, Raphaela; Stratakis, Constantine A.

In: Human Molecular Genetics, Vol. 20, No. 1, 01.2011, p. 165-175.

Research output: Contribution to journalArticle

Almeida, Madson Q. ; Tsang, Kit Man ; Cheadle, Chris ; Watkins, Tonya ; Grivel, Jean-Charles B. ; Nesterova, Maria ; Goldbach-Mansky, Raphaela ; Stratakis, Constantine A. / Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions : A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors. In: Human Molecular Genetics. 2011 ; Vol. 20, No. 1. pp. 165-175.
@article{fe40bbb374cd4d8db57571393680b48c,
title = "Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions: A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors",
abstract = "Patients with genetic defects of the cyclic (c) adenosine-monophosphate (AMP)-signaling pathway and those with neonatal-onset multisystem inflammatory disease (NOMID) develop tumor-like lesions of the long bones. The molecular basis of this similarity is unknown. NOMID is caused by inappropriate caspase-1 activity, which in turn activates the inflammasome. The present study demonstrates that NOMID bone lesions are derived from the same osteoblast progenitor cells that form fibroblastoid tumors in mice and humans with defects that lead to increased cAMP-dependent protein kinase A (PKA) signaling. NOMID tumor cells showed high PKA activity, and an increase in their cAMP signaling led to PKA-specific activation of caspase-1. Increased PKA led to inflammation-independent activation of caspase-1 via over-expression of the proto-oncogene (and early osteoblast factor) Ets-1. In NOMID tumor cells, as in cells with defective PKA regulation, increased prostaglandin E2 (PGE2) led to increased cAMP levels and activation of Wnt signaling, like in other states of inappropriate PKA activity. Caspase-1 and PGE2 inhibition led to a decrease in cell proliferation of both NOMID and cells with abnormal PKA. These data reveal a previously unsuspected link between abnormal cAMP signaling and defective regulation of the inflammasome and suggest that caspase-1 and PGE2 inhibition may be therapeutic targets in bone lesions associated with defects of these two pathways.",
author = "Almeida, {Madson Q.} and Tsang, {Kit Man} and Chris Cheadle and Tonya Watkins and Grivel, {Jean-Charles B.} and Maria Nesterova and Raphaela Goldbach-Mansky and Stratakis, {Constantine A.}",
year = "2011",
month = "1",
doi = "10.1093/hmg/ddq455",
language = "English",
volume = "20",
pages = "165--175",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Protein kinase A regulates caspase-1 via Ets-1 in bone stromal cell-derived lesions

T2 - A link between cyclic AMP and pro-inflammatory pathways in osteoblast progenitors

AU - Almeida, Madson Q.

AU - Tsang, Kit Man

AU - Cheadle, Chris

AU - Watkins, Tonya

AU - Grivel, Jean-Charles B.

AU - Nesterova, Maria

AU - Goldbach-Mansky, Raphaela

AU - Stratakis, Constantine A.

PY - 2011/1

Y1 - 2011/1

N2 - Patients with genetic defects of the cyclic (c) adenosine-monophosphate (AMP)-signaling pathway and those with neonatal-onset multisystem inflammatory disease (NOMID) develop tumor-like lesions of the long bones. The molecular basis of this similarity is unknown. NOMID is caused by inappropriate caspase-1 activity, which in turn activates the inflammasome. The present study demonstrates that NOMID bone lesions are derived from the same osteoblast progenitor cells that form fibroblastoid tumors in mice and humans with defects that lead to increased cAMP-dependent protein kinase A (PKA) signaling. NOMID tumor cells showed high PKA activity, and an increase in their cAMP signaling led to PKA-specific activation of caspase-1. Increased PKA led to inflammation-independent activation of caspase-1 via over-expression of the proto-oncogene (and early osteoblast factor) Ets-1. In NOMID tumor cells, as in cells with defective PKA regulation, increased prostaglandin E2 (PGE2) led to increased cAMP levels and activation of Wnt signaling, like in other states of inappropriate PKA activity. Caspase-1 and PGE2 inhibition led to a decrease in cell proliferation of both NOMID and cells with abnormal PKA. These data reveal a previously unsuspected link between abnormal cAMP signaling and defective regulation of the inflammasome and suggest that caspase-1 and PGE2 inhibition may be therapeutic targets in bone lesions associated with defects of these two pathways.

AB - Patients with genetic defects of the cyclic (c) adenosine-monophosphate (AMP)-signaling pathway and those with neonatal-onset multisystem inflammatory disease (NOMID) develop tumor-like lesions of the long bones. The molecular basis of this similarity is unknown. NOMID is caused by inappropriate caspase-1 activity, which in turn activates the inflammasome. The present study demonstrates that NOMID bone lesions are derived from the same osteoblast progenitor cells that form fibroblastoid tumors in mice and humans with defects that lead to increased cAMP-dependent protein kinase A (PKA) signaling. NOMID tumor cells showed high PKA activity, and an increase in their cAMP signaling led to PKA-specific activation of caspase-1. Increased PKA led to inflammation-independent activation of caspase-1 via over-expression of the proto-oncogene (and early osteoblast factor) Ets-1. In NOMID tumor cells, as in cells with defective PKA regulation, increased prostaglandin E2 (PGE2) led to increased cAMP levels and activation of Wnt signaling, like in other states of inappropriate PKA activity. Caspase-1 and PGE2 inhibition led to a decrease in cell proliferation of both NOMID and cells with abnormal PKA. These data reveal a previously unsuspected link between abnormal cAMP signaling and defective regulation of the inflammasome and suggest that caspase-1 and PGE2 inhibition may be therapeutic targets in bone lesions associated with defects of these two pathways.

UR - http://www.scopus.com/inward/record.url?scp=79956313489&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956313489&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddq455

DO - 10.1093/hmg/ddq455

M3 - Article

C2 - 20940146

AN - SCOPUS:79956313489

VL - 20

SP - 165

EP - 175

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 1

ER -